Literature DB >> 8235512

Solvent exposure, alcohol consumption and liver injury in workers manufacturing paint.

D Rees1, N Soderlund, R Cronje, E Song, D Kielkowski, J Myers.   

Abstract

Liver enzyme activity was examined in 89 South African paint makers currently exposed to a mixture of organic solvents at fairly low levels. However, the duration of exposure was substantial for many. Fifty-eight workers (65%) had at least one enzyme value above the upper reference limit. Gamma glutamyl transferase (gamma GT) activity was elevated in 46% of the workers and aspartate aminotransferase (ASAT) in 52%. In a comparison between workers with high and low solvent exposure, the gamma GT and ASAT values were higher in the most exposed group (eg, gamma GT mean 108 versus 69 U.l-1, P > 0.05). Adjustment for confounding by alcohol consumption and body mass index eliminated the differences due to exposure. It was concluded that the measures of liver injury used did not demonstrate solvent-induced hepatic damage but that excessive alcohol consumption was an important factor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8235512     DOI: 10.5271/sjweh.1478

Source DB:  PubMed          Journal:  Scand J Work Environ Health        ISSN: 0355-3140            Impact factor:   5.024


  3 in total

1.  Hepatotoxic effects of solvent exposure around permissible limits and alcohol consumption in printers over a 4-year period.

Authors:  M Nasterlack; G Triebig; O Stelzer
Journal:  Int Arch Occup Environ Health       Date:  1994       Impact factor: 3.015

2.  Examination of the relationships between environmental exposures to volatile organic compounds and biochemical liver tests: application of canonical correlation analysis.

Authors:  Jing Liu; Wanzer Drane; Xuefeng Liu; Tiejian Wu
Journal:  Environ Res       Date:  2008-12-30       Impact factor: 6.498

3.  Sonographic assessment of petroleum-induced hepatotoxicity in Nigerians: does biochemical assessment underestimate liver damage?

Authors:  Angel-Mary Anakwue; Raphael Anakwue; Mark Okeji; Felicitas Idigo; Kenneth Agwu; Uloma Nwogu
Journal:  Afr Health Sci       Date:  2017-03       Impact factor: 0.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.